Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia

Leuk Lymphoma. 2021 Mar;62(3):716-721. doi: 10.1080/10428194.2020.1838508. Epub 2020 Nov 19.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Piperidines
  • Protein Kinase Inhibitors / adverse effects
  • Pyrazoles / adverse effects
  • Pyrimidines / adverse effects

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine